Olink® Reveal is an NGS-based proteomics solution offering high-throughput biomarker analysis with minimal hands-on time.

The test will be accessible via healthcare professional referrals in Western Australia and the Northern Territory.

Among other topics, conversations at the meeting focused on new methods for measuring proteins as well as opportunities for automation and AI.

Alamar's technology empowers scientists to achieve groundbreaking insights in biomarker discovery, drug development, and disease research. Through these new partnerships, researchers in Asia-Pacific ...

Event to be held via webcast on March 25, 2025 at 4:00 p.m. ETTo highlight differentiated drug discovery capabilities with its Generative ...

PORTLAND, IL, UNITED STATES, March 11, 2025 /EINPresswire / -- The proteomics market is witnessing significant growth propelled by advancements in technology, such as mass spectrometry and protein ...

Proteomics International Laboratories has launched its novel PromarkerD test for diabetic kidney disease in WA and the NT ...

Proteomics International Laboratories’ PromarkerD blood test has proven to be a step up in predicting chronic kidney disease ...

Social isolation and loneliness scores were calculated for each individual and a high-throughput proteomics platform from Olink was used to analyze the blood samples and identify any proteins ...

Proteomics International aptly has chosen World Kidney Day to launch its predictive test for diabetic kidney disease locally.